Trials / Unknown
UnknownNCT05946122
Effect of Atorvastatin as a Renal Protection in Patients With Systemic Inflammatory Response Syndrome Using Renal Arterial Resistive Index
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 106 (estimated)
- Sponsor
- Minia University · Academic / Other
- Sex
- All
- Age
- 25 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Offering renal protection in systemic inflammatory response syndrome by atorvastatin
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atorvastatin 40 Mg Oral Tablet | oral atorvastatin for renal protection |
| DRUG | placebo drug | tablet resembles atorvastatin |
Timeline
- Start date
- 2023-05-30
- Primary completion
- 2023-12-12
- Completion
- 2023-12-30
- First posted
- 2023-07-14
- Last updated
- 2023-07-14
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05946122. Inclusion in this directory is not an endorsement.